» Articles » PMID: 19307590

Binding of an Octylglucoside Detergent Molecule in the Second Substrate (S2) Site of LeuT Establishes an Inhibitor-bound Conformation

Overview
Specialty Science
Date 2009 Mar 25
PMID 19307590
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

The first crystal structure of the neurotransmitter/sodium symporter homolog LeuT revealed an occluded binding pocket containing leucine and 2 Na(+); later structures showed tricyclic antidepressants (TCAs) in an extracellular vestibule approximately 11 A above the bound leucine and 2 Na(+). We recently found this region to be a second binding (S2) site and that binding of substrate to this site triggers Na(+)-coupled substrate symport. Here, we show a profound inhibitory effect of n-octyl-beta-d-glucopyranoside (OG), the detergent used for LeuT crystallization, on substrate binding to the S2 site. In parallel, we determined at 2.8 A the structure of LeuT-E290S, a mutant that, like LeuT-WT, binds 2 substrate molecules. This structure was similar to that of WT and clearly revealed an OG molecule in the S2 site. We also observed electron density at the S2 site in LeuT-WT crystals, and this also was accounted for by an OG molecule in that site. Computational analyses, based on the available crystal structures of LeuT, indicated the nature of structural arrangements in the extracellular region of LeuT that differentiate the actions of substrates from inhibitors bound in the S2 site. We conclude that the current LeuT crystal structures, all of which have been solved in OG, represent functionally blocked forms of the transporter, whereas a substrate bound in the S2 site will promote a different state that is essential for Na(+)-coupled symport.

Citing Articles

Exploring the Structural Dynamics of LeuT Using EPR Spectroscopy: A Focus on Transmembrane Helix 10.

Tsalagradas P, Eke C, Andrews C, MacMillan F J Neurochem. 2025; 169(3):e70034.

PMID: 40052253 PMC: 11886772. DOI: 10.1111/jnc.70034.


Structural basis of urea transport by Arabidopsis thaliana DUR3.

An W, Gao Y, Liu L, Bai Q, Zhao J, Zhao Y Nat Commun. 2025; 16(1):1782.

PMID: 39972035 PMC: 11840088. DOI: 10.1038/s41467-025-56943-2.


The Structural Basis of the Activity Cliff in Modafinil-Based Dopamine Transporter Inhibitors.

Lee K, Camacho-Hernandez G, Newman A, Shi L Biomolecules. 2024; 14(6).

PMID: 38927116 PMC: 11202288. DOI: 10.3390/biom14060713.


Structural and molecular basis of choline uptake into the brain by FLVCR2.

Cater R, Mukherjee D, Gil-Iturbe E, Erramilli S, Chen T, Koo K Nature. 2024; 629(8012):704-709.

PMID: 38693257 PMC: 11168207. DOI: 10.1038/s41586-024-07326-y.


A comparative review on the well-studied GAT1 and the understudied BGT-1 in the brain.

Bhatt M, Gauthier-Manuel L, Lazzarin E, Zerlotti R, Ziegler C, Bazzone A Front Physiol. 2023; 14:1145973.

PMID: 37123280 PMC: 10137170. DOI: 10.3389/fphys.2023.1145973.


References
1.
Singh S, Yamashita A, Gouaux E . Antidepressant binding site in a bacterial homologue of neurotransmitter transporters. Nature. 2007; 448(7156):952-6. DOI: 10.1038/nature06038. View

2.
Amara S, Sonders M . Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend. 1998; 51(1-2):87-96. DOI: 10.1016/s0376-8716(98)00068-4. View

3.
Phillips J, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E . Scalable molecular dynamics with NAMD. J Comput Chem. 2005; 26(16):1781-802. PMC: 2486339. DOI: 10.1002/jcc.20289. View

4.
Gu H, Wall S, Rudnick G . Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem. 1994; 269(10):7124-30. View

5.
Quick M, Javitch J . Monitoring the function of membrane transport proteins in detergent-solubilized form. Proc Natl Acad Sci U S A. 2007; 104(9):3603-8. PMC: 1805550. DOI: 10.1073/pnas.0609573104. View